These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34121225)

  • 1. An autopsy case of PARK2 due to a homozygous exon 2 deletion of parkin and associated with α-synucleinopathy.
    Sakuwa M; Adachi T; Yoshida K; Adachi Y; Nakano T; Hanajima R
    Neuropathology; 2021 Aug; 41(4):293-300. PubMed ID: 34121225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lewy body pathology in a patient with a homozygous parkin deletion.
    Miyakawa S; Ogino M; Funabe S; Uchino A; Shimo Y; Hattori N; Ichinoe M; Mikami T; Saegusa M; Nishiyama K; Mori H; Mizuno Y; Murayama S; Mochizuki H
    Mov Disord; 2013 Mar; 28(3):388-91. PubMed ID: 23401296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation.
    Sharp ME; Marder KS; Côté L; Clark LN; Nichols WC; Vonsattel JP; Alcalay RN
    Mov Disord; 2014 Apr; 29(4):566-8. PubMed ID: 24375549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene.
    Hayashi S; Wakabayashi K; Ishikawa A; Nagai H; Saito M; Maruyama M; Takahashi T; Ozawa T; Tsuji S; Takahashi H
    Mov Disord; 2000 Sep; 15(5):884-8. PubMed ID: 11009195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkin-positive autosomal recessive juvenile Parkinsonism with alpha-synuclein-positive inclusions.
    Sasaki S; Shirata A; Yamane K; Iwata M
    Neurology; 2004 Aug; 63(4):678-82. PubMed ID: 15326242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between Parkin and
    Madsen DA; Schmidt SI; Blaabjerg M; Meyer M
    Cells; 2021 Jan; 10(2):. PubMed ID: 33572534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of nigral neurodegeneration in Park2 and regulation of parkin protein by other proteins.
    Hattori N; Machida Y; Sato S; Noda K; Iijima-Kitami M; Kubo S; Mizuno Y
    J Neural Transm Suppl; 2006; (70):205-8. PubMed ID: 17017530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.
    Schlossmacher MG; Frosch MP; Gai WP; Medina M; Sharma N; Forno L; Ochiishi T; Shimura H; Sharon R; Hattori N; Langston JW; Mizuno Y; Hyman BT; Selkoe DJ; Kosik KS
    Am J Pathol; 2002 May; 160(5):1655-67. PubMed ID: 12000718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2.
    Orimo S; Amino T; Yokochi M; Kojo T; Uchihara T; Takahashi A; Wakabayashi K; Takahashi H; Hattori N; Mizuno Y
    Mov Disord; 2005 Oct; 20(10):1350-3. PubMed ID: 16001409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Variations and Neuropathologic Features of Patients with PRKN Mutations.
    Seike N; Yokoseki A; Takeuchi R; Saito K; Miyahara H; Miyashita A; Ikeda T; Aida I; Nakajima T; Kanazawa M; Wakabayashi M; Toyoshima Y; Takahashi H; Matsumoto R; Toda T; Onodera O; Ishikawa A; Ikeuchi T; Kakita A
    Mov Disord; 2021 Jul; 36(7):1634-1643. PubMed ID: 33570211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lewy bodies and parkinsonism in families with parkin mutations.
    Farrer M; Chan P; Chen R; Tan L; Lincoln S; Hernandez D; Forno L; Gwinn-Hardy K; Petrucelli L; Hussey J; Singleton A; Tanner C; Hardy J; Langston JW
    Ann Neurol; 2001 Sep; 50(3):293-300. PubMed ID: 11558785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease.
    Hou X; Fiesel FC; Truban D; Castanedes Casey M; Lin WL; Soto AI; Tacik P; Rousseau LG; Diehl NN; Heckman MG; Lorenzo-Betancor O; Ferrer I; Arbelo JM; Steele JC; Farrer MJ; Cornejo-Olivas M; Torres L; Mata IF; Graff-Radford NR; Wszolek ZK; Ross OA; Murray ME; Dickson DW; Springer W
    Autophagy; 2018; 14(8):1404-1418. PubMed ID: 29947276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkin disease: a clinicopathologic entity?
    Doherty KM; Silveira-Moriyama L; Parkkinen L; Healy DG; Farrell M; Mencacci NE; Ahmed Z; Brett FM; Hardy J; Quinn N; Counihan TJ; Lynch T; Fox ZV; Revesz T; Lees AJ; Holton JL
    JAMA Neurol; 2013 May; 70(5):571-9. PubMed ID: 23459986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.
    Abbas N; Lücking CB; Ricard S; Dürr A; Bonifati V; De Michele G; Bouley S; Vaughan JR; Gasser T; Marconi R; Broussolle E; Brefel-Courbon C; Harhangi BS; Oostra BA; Fabrizio E; Böhme GA; Pradier L; Wood NW; Filla A; Meco G; Denefle P; Agid Y; Brice A
    Hum Mol Genet; 1999 Apr; 8(4):567-74. PubMed ID: 10072423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics.
    Cornejo-Olivas MR; Torres L; Mata IF; Mazzetti P; Rivas D; Cosentino C; Inca-Martinez M; Cuba JM; Zabetian CP; Leverenz JB
    Parkinsonism Relat Disord; 2015 May; 21(5):444-8. PubMed ID: 25817512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of locus coeruleus neurons and reduced startle in parkin null mice.
    Von Coelln R; Thomas B; Savitt JM; Lim KL; Sasaki M; Hess EJ; Dawson VL; Dawson TM
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10744-9. PubMed ID: 15249681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India.
    Vinish M; Prabhakar S; Khullar M; Verma I; Anand A
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):166-70. PubMed ID: 19734163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
    Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
    J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.